82_FR_36980 82 FR 36830 - Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018

82 FR 36830 - Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 82, Issue 150 (August 7, 2017)

Page Range36830-36834
FR Document2017-16439

The Drug Enforcement Administration (DEA) proposes to establish the 2018 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.

Federal Register, Volume 82 Issue 150 (Monday, August 7, 2017) 
[Federal Register Volume 82, Number 150 (Monday, August 7, 2017)]
[Notices]
[Pages 36830-36834]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-16439]



[[Page 36830]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-471N]


Proposed Aggregate Production Quotas for Schedule I and II 
Controlled Substances and Assessment of Annual Needs for the List I 
Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notice with request for comments.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) proposes to 
establish the 2018 aggregate production quotas for controlled 
substances in schedules I and II of the Controlled Substances Act and 
assessment of annual needs for the list I chemicals ephedrine, 
pseudoephedrine, and phenylpropanolamine.

DATES: Interested persons may file written comments on this notice in 
accordance with 21 CFR 1303.11(c) and 1315.11(d). Electronic comments 
must be submitted, and written comments must be postmarked, on or 
before September 6, 2017. Commenters should be aware that the 
electronic Federal Docket Management System will not accept comments 
after 11:59 p.m. Eastern Time on the last day of the comment period.
    Based on comments received in response to this notice, the 
Administrator may hold a public hearing on one or more issues raised. 
In the event the Administrator decides in his sole discretion to hold 
such a hearing, the Administrator will publish a notice of any such 
hearing in the Federal Register. After consideration of any comments or 
objections, or after a hearing, if one is held, the Administrator will 
publish in the Federal Register a final order establishing the 2018 
aggregate production quotas for schedule I and II controlled 
substances, and an assessment of annual needs for the list I chemicals 
ephedrine, pseudoephedrine, and phenylpropanolamine.

ADDRESSES: To ensure proper handling of comments, please reference 
``Docket No. DEA-471N'' on all correspondence, including any 
attachments. The Drug Enforcement Administration encourages that all 
comments be submitted electronically through the Federal eRulemaking 
Portal which provides the ability to type short comments directly into 
the comment field on the Web page or attach a file for lengthier 
comments. Please go to http://www.regulations.gov and follow the online 
instructions at that site for submitting comments. Upon completion of 
your submission you will receive a Comment Tracking Number for your 
comment. Please be aware that submitted comments are not 
instantaneously available for public view on Regulations.gov. If you 
have received a Comment Tracking Number, your comment has been 
successfully submitted and there is no need to resubmit the same 
comment. Paper comments that duplicate electronic submissions are not 
necessary and are discouraged. Should you wish to mail a paper comment 
in lieu of an electronic comment, it should be sent via regular or 
express mail to: Drug Enforcement Administration, Attention: DEA 
Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

FOR FURTHER INFORMATION CONTACT: Michael J. Lewis, Diversion Control 
Division, Drug Enforcement Administration; Mailing Address: 8701 
Morrissette Drive, Springfield, Virginia 22152, Telephone: (202) 598-
6812.

SUPPLEMENTARY INFORMATION: 

Posting of Public Comments

    Please note that all comments received in response to this docket 
are considered part of the public record. They will, unless reasonable 
cause is given, be made available by the Drug Enforcement 
Administration (DEA) for public inspection online at http://www.regulations.gov. Such information includes personal identifying 
information (such as your name, address, etc.) voluntarily submitted by 
the commenter.
    The Freedom of Information Act (FOIA) applies to all comments 
received. If you want to submit personal identifying information (such 
as your name, address, etc.) as part of your comment, but do not want 
it to be made publicly available, you must include the phrase 
``PERSONAL IDENTIFYING INFORMATION'' in the first paragraph of your 
comment. You must also place all the personal identifying information 
you do not want made publicly available in the first paragraph of your 
comment and identify what information you want redacted.
    If you want to submit confidential business information as part of 
your comment, but do not want it to be made publicly available, you 
must include the phrase ``CONFIDENTIAL BUSINESS INFORMATION'' in the 
first paragraph of your comment. You must also prominently identify 
confidential business information to be redacted within the comment.
    Comments containing personal identifying information or 
confidential business information identified and located as directed 
above will generally be made available in redacted form. If a comment 
contains so much confidential business information or personal 
identifying information that it cannot be effectively redacted, all or 
part of that comment may not be made publicly available. Comments 
posted to http://www.regulations.gov may include any personal 
identifying information (such as name, address, and phone number) 
included in the text of your electronic submission that is not 
identified as directed above as confidential.
    An electronic copy of this document is available at http://www.regulations.gov for easy reference.

Legal Authority

    Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) 
requires the Attorney General to establish aggregate production quotas 
for each basic class of controlled substance listed in schedules I and 
II and for the list I chemicals ephedrine, pseudoephedrine, and 
phenylpropanolamine. The Attorney General has delegated this function 
to the Administrator of the DEA pursuant to 28 CFR 0.100.

Analysis for Proposed 2018 Aggregate Production Quotas and Assessment 
of Annual Needs

    The proposed year 2018 aggregate production quotas and assessment 
of annual needs represent those quantities of schedule I and II 
controlled substances, and the list I chemicals ephedrine, 
pseudoephedrine, and phenylpropanolamine, to be manufactured in the 
United States in 2018 to provide for the estimated medical, scientific, 
research, and industrial needs of the United States, lawful export 
requirements, and the establishment and maintenance of reserve stocks. 
These quotas include imports of ephedrine, pseudoephedrine, and 
phenylpropanolamine, but do not include imports of controlled 
substances for use in industrial processes.
    In determining the proposed 2018 aggregate production quotas and 
assessment of annual needs, the Acting Administrator has taken into 
account the criteria pursuant to 21 U.S.C. 826(a) and in accordance 
with 21 CFR 1303.11 (aggregate production quotas for controlled 
substances) and 21 CFR 1315.11 (assessment of annual needs for 
ephedrine, pseudoephedrine, and

[[Page 36831]]

phenylpropanolamine). The DEA proposes the aggregate production quotas 
and assessment of annual needs for 2018 by considering: (1) Total net 
disposal of each class or chemical by all manufacturers and chemical 
importers during the current and two preceding years; (2) trends in the 
national rate of net disposal of the class or chemical; (3) total 
actual (or estimated) inventories of the class or chemical and of all 
substances manufactured from the class or chemical, and trends in 
inventory accumulation; (4) projected demand for each class or chemical 
as indicated by procurement and import quotas requested in accordance 
with 21 CFR 1303.12, 1315.32, and 1315.34; and (5) other factors 
affecting medical, scientific, research, and industrial needs of the 
United States and lawful export requirements, as the Acting 
Administrator finds relevant. These quotas do not include imports of 
controlled substances for use in industrial processes.
    Other factors the Acting Administrator considered in calculating 
the aggregate production quotas, but not the assessment of annual 
needs, include product development requirements of both bulk and 
finished dosage form manufacturers, and other pertinent information. In 
determining the proposed 2018 assessment of annual needs, the DEA used 
the calculation methodology previously described in the 2010 and 2011 
assessment of annual needs (74 FR 60294, Nov. 20, 2009, and 75 FR 
79407, Dec. 20, 2010, respectively).
    The Acting Administrator, therefore, proposes to establish the 2018 
aggregate production quotas for certain schedule I and II controlled 
substances and assessment of annual needs for the list I chemicals 
ephedrine, pseudoephedrine, and phenylpropanolamine, expressed in grams 
of anhydrous acid or base, as follows:

------------------------------------------------------------------------
                                                           Proposed 2018
                                                              quotas
                       Basic class                       ---------------
                                                                (g)
------------------------------------------------------------------------
                               Schedule I
------------------------------------------------------------------------
1-(1-Phenylcyclohexyl)pyrrolidine.......................              10
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201).......              30
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694)......              30
1-[1-(2-Thienyl)cyclohexyl]piperidine...................              15
1-Benzylpiperazine......................................              25
1-Methyl-4-phenyl-4-propionoxypiperidine................               2
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)........              30
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).......              30
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).......              30
2-(2,5-Dimethoxy-4-n-propylphenyl)ethanamine (2C-P).....              30
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)................              30
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-                                 25
 methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B;
 Cimbi-36)..............................................
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).......              30
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-                                25
 methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C;
 Cimbi-82)..............................................
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).........              30
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-                                  30
 methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I;
 Cimbi-5)...............................................
2,5-Dimethoxy-4-ethylamphetamine (DOET).................              25
2,5-Dimethoxy-4-n-propylthiophenethylamine..............              25
2,5-Dimethoxyamphetamine................................              25
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)              30
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-              30
 T-4)...................................................
3,4,5-Trimethoxyamphetamine.............................              25
3,4-Methylenedioxyamphetamine (MDA).....................              55
3,4-Methylenedioxymethamphetamine (MDMA)................              50
3,4-Methylenedioxy-N-ethylamphetamine (MDEA)............              40
3,4-Methylenedioxy-N-methylcathinone (methylone)........              40
3,4-Methylenedioxypyrovalerone (MDPV)...................              35
3-FMC; 3-Fluoro-N-methylcathinone.......................              25
3-Methylfentanyl........................................              30
3-Methylthiofentanyl....................................              30
4-Bromo-2,5-dimethoxyamphetamine (DOB)..................              25
4-Bromo-2,5-dimethoxyphenethylamine (2-CB)..............              25
4-Fluoroisobutyryl fentanyl.............................              30
4-FMC; Flephedrone......................................              25
4-MEC; 4-Methyl-N-ethylcathinone........................              25
4-Methoxyamphetamine....................................             150
4-Methyl-2,5-dimethoxyamphetamine (DOM).................              25
4-Methylaminorex........................................              25
4-Methyl-N-methylcathinone (mephedrone).................              45
4-Methyl-[alpha]-pyrrolidinopropiophenone (4-MePPP).....              25
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-               50
 phenol.................................................
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-                40
 phenol (cannabicyclohexanol or CP-47,497 C8-homolog)...
5F-ADB; 5F-MDMB-PINACA (methyl 2-(1-(5-fluoropentyl)-1H-              30
 indazole-3-carboxamido)-3,3-dimethylbutanoate).........
5F-AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-                   30
 carboxamido)-3-methylbutanoate)........................
5F-APINACA; 5F-AKB48 (N-(adamantan-1-yl)-1-(5-                        30
 fluoropentyl)-1H-indazole-3-carboxamide)...............
5-Fluoro-PB-22; 5F-PB-22................................              20
5-Fluoro-UR144, XLR11 ([1-(5-fluoro-pentyl)-1Hindol-3-                25
 yl](2,2,3,3-tetramethylcyclopropyl)methanone...........
5-Methoxy-3,4-methylenedioxyamphetamine.................              25
5-Methoxy-N,N-diisopropyltryptamine.....................              25

[[Page 36832]]

 
5-Methoxy-N,N-dimethyltryptamine........................              25
AB-CHMINACA.............................................              30
AB-FUBINACA.............................................              50
AB-PINACA...............................................              30
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-             30
 (4-fluorobenzyl)-1H-indazole-3-carboxamide)............
Acetyl Fentanyl.........................................             100
Acetyl-alpha-methylfentanyl.............................              30
Acetyldihydrocodeine....................................              30
Acetylmethadol..........................................               2
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-               50
 pentyl-1H-indazole-3-carboxamide)......................
AH-7921.................................................              30
Allylprodine............................................               2
Alphacetylmethadol......................................               2
alpha-Ethyltryptamine...................................              25
Alphameprodine..........................................               2
Alphamethadol...........................................               2
alpha-Methylfentanyl....................................              30
alpha-Methylthiofentanyl................................              30
alpha-Methyltryptamine (AMT)............................              25
alpha-Pyrrolidinobutiophenone ([alpha]-PBP).............              25
alpha-Pyrrolidinopentiophenone ([alpha]-PVP)............              25
Aminorex................................................              25
APINCA, AKB48 (N-(1-adamantyl)-1-pentyl-1H-indazole-3-                25
 carboxamide)...........................................
Benzylmorphine..........................................              30
Betacetylmethadol.......................................               2
beta-Hydroxy-3-methylfentanyl...........................              30
beta-Hydroxyfentanyl....................................              30
beta-Hydroxythiofentanyl................................              30
Betameprodine...........................................               2
Betamethadol............................................               4
Betaprodine.............................................               2
Bufotenine..............................................               3
Butylone................................................              25
Butyryl fentanyl........................................              30
Cathinone...............................................              24
Codeine methylbromide...................................              30
Codeine-N-oxide.........................................             192
Desomorphine............................................              25
Diethyltryptamine.......................................              25
Difenoxin...............................................           8,225
Dihydromorphine.........................................       1,000,160
Dimethyltryptamine......................................              35
Dipipanone..............................................               5
Etorphine...............................................              30
Fenethylline............................................              30
Furanyl fentanyl........................................              30
gamma-Hydroxybutyric acid...............................      37,130,000
Heroin..................................................              45
Hydromorphinol..........................................              40
Hydroxypethidine........................................               2
Ibogaine................................................              30
JWH-018 and AM678 (1-Pentyl-3-(1-naphthoyl)indole)......              35
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).................              45
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).................              45
JWH-081 (1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole).....              30
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).......              30
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-                             35
 naphthoyl)indole)......................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).......              30
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole)......              30
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).......              30
Lysergic acid diethylamide (LSD)........................              40
MAB-CHMINACA; ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1-                30
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
 carboxamide)...........................................
MDMB-CHMICA; MMB-CHMINACA (methyl 2-(1-                               30
 (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-
 dimethylbutanoate).....................................
MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-              30
 3-carboxamido)-3,3-dimethylbutanoate)..................
Marihuana...............................................         443,680
Mecloqualone............................................              30
Mescaline...............................................              25
Methaqualone............................................              60
Methcathinone...........................................              25

[[Page 36833]]

 
Methyldesorphine........................................               5
Methyldihydromorphine...................................               2
Morphine methylbromide..................................               5
Morphine methylsulfonate................................               5
Morphine-N-oxide........................................             150
N,N-Dimethylamphetamine.................................              25
Naphyrone...............................................              25
N-Ethyl-1-phenylcyclohexylamine.........................               5
N-Ethylamphetamine......................................              24
N-Hydroxy-3,4-methylenedioxyamphetamine.................              24
Noracymethadol..........................................               2
Norlevorphanol..........................................              55
Normethadone............................................               2
Normorphine.............................................              40
Para-fluorofentanyl.....................................              25
Parahexyl...............................................               5
PB-22; QUPIC............................................              20
Pentedrone..............................................              25
Pentylone...............................................              25
Phenomorphan............................................               2
Pholcodine..............................................               5
Psilocybin..............................................              30
Psilocyn................................................              50
SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2-                              45
 methoxyphenylacetyl)indole)............................
SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-benzoyl]indole)              30
Tetrahydrocannabinols...................................         384,460
Thiofentanyl............................................              25
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-                           30
 yl](naphthalen-1-yl)methanone).........................
Tilidine................................................              25
Trimeperidine...........................................               2
UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3-                              25
 tetramethylcyclopropyl)methanone.......................
U-47700.................................................              30
------------------------------------------------------------------------
                               Schedule II
------------------------------------------------------------------------
1-Phenylcyclohexylamine.................................               4
1-Piperidinocyclohexanecarbonitrile.....................               4
4-Anilino-N-phenethyl-4-piperidine (ANPP)...............       1,342,320
Alfentanil..............................................           2,538
Alphaprodine............................................               2
Amobarbital.............................................          18,894
Amphetamine (for conversion)............................      11,280,000
Amphetamine (for sale)..................................      39,856,000
Carfentanil.............................................              20
Cocaine.................................................          92,120
Codeine (for conversion)................................      15,040,000
Codeine (for sale)......................................      40,015,800
Dextropropoxyphene......................................              35
Dihydrocodeine..........................................         264,140
Dihydroetorphine........................................               2
Diphenoxylate (for conversion)..........................          14,100
Diphenoxylate (for sale)................................         770,800
Ecgonine................................................          88,134
Ethylmorphine...........................................              30
Etorphine hydrochloride.................................              32
Fentanyl................................................       1,342,320
Glutethimide............................................               2
Hydrocodone (for conversion)............................         114,680
Hydrocodone (for sale)..................................      50,348,280
Hydromorphone...........................................       4,547,720
Isomethadone............................................              30
Levo-alphacetylmethadol (LAAM)..........................               5
Levomethorphan..........................................              30
Levorphanol.............................................          12,126
Lisdexamfetamine........................................      17,869,000
Meperidine..............................................       2,717,540
Meperidine Intermediate--A..............................               5
Meperidine Intermediate--B..............................              30
Meperidine Intermediate--C..............................               5
Metazocine..............................................              15
Methadone (for sale)....................................      22,278,000

[[Page 36834]]

 
Methadone Intermediate..................................      24,064,000
Methamphetamine.........................................       1,446,754
------------------------------------------------------------------------
[900,000 grams of levo-desoxyephedrine for use in a non-controlled, non-
 prescription product; 600,000 grams for methamphetamine mostly for
 conversion to a schedule III product; and 39,100 grams for
 methamphetamine (for sale)]
------------------------------------------------------------------------
Methylphenidate.........................................      60,724,000
Morphine (for conversion)...............................       4,089,000
Morphine (for sale).....................................      33,958,440
Nabilone................................................          17,860
Noroxymorphone (for conversion).........................      14,044,540
Noroxymorphone (for sale)...............................         376,000
Opium (powder)..........................................          84,600
Opium (tincture)........................................         564,000
Oripavine...............................................      24,534,000
Oxycodone (for conversion)..............................       2,453,400
Oxycodone (for sale)....................................      95,692,000
Oxymorphone (for conversion)............................      20,962,000
Oxymorphone (for sale)..................................       3,395,280
Pentobarbital...........................................      25,850,000
Phenazocine.............................................               5
Phencyclidine...........................................              35
Phenmetrazine...........................................              25
Phenylacetone...........................................              40
Racemethorphan..........................................               5
Racemorphan.............................................               5
Remifentanil............................................           2,820
Secobarbital............................................         161,682
Sufentanil..............................................           1,880
Tapentadol..............................................      18,388,280
Thebaine................................................      94,000,000
------------------------------------------------------------------------
                            List I Chemicals
------------------------------------------------------------------------
Ephedrine (for conversion)..............................          47,000
Ephedrine (for sale)....................................       4,136,000
Phenylpropanolamine (for conversion)....................      14,100,000
Phenylpropanolamine (for sale)..........................       7,990,000
Pseudoephedrine (for conversion)........................              40
Pseudoephedrine (for sale)..............................     169,200,000
------------------------------------------------------------------------

    The Acting Administrator further proposes that aggregate production 
quotas for all other schedule I and II controlled substances included 
in 21 CFR 1308.11 and 1308.12 remain at zero. In accordance with 21 CFR 
1303.13 and 21 CFR 1315.13, upon consideration of the relevant factors, 
the Acting Administrator may adjust the 2018 aggregate production 
quotas and assessment of annual needs as needed.

Conclusion

    After consideration of any comments or objections, or after a 
hearing, if one is held, the Acting Administrator will issue and 
publish in the Federal Register a final order establishing the 2018 
aggregate production quota for controlled substances in schedules I and 
II and establishing an assessment of annual needs for the list I 
chemicals ephedrine, pseudoephedrine, and phenylpropanolamine, 21 CFR 
1303.11(c) and 1315.11(f).

    Dated: July 27, 2017.
Chuck Rosenberg,
Acting Administrator.
[FR Doc. 2017-16439 Filed 8-4-17; 8:45 am]
 BILLING CODE 4410-09-P

36830 Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices DEPARTMENT OF JUSTICE or attach a file for lengthier comments. business information to be redacted Please go to http://www.regulations.gov within the comment. Drug Enforcement Administration and follow the online instructions at Comments containing personal [Docket No. DEA–471N] that site for submitting comments. Upon identifying information or confidential completion of your submission you will business information identified and Proposed Aggregate Production receive a Comment Tracking Number for located as directed above will generally Quotas for Schedule I and II Controlled your comment. Please be aware that be made available in redacted form. If a Substances and Assessment of submitted comments are not comment contains so much confidential Annual Needs for the List I Chemicals instantaneously available for public business information or personal Ephedrine, Pseudoephedrine, and view on Regulations.gov. If you have identifying information that it cannot be Phenylpropanolamine for 2018 received a Comment Tracking Number, effectively redacted, all or part of that your comment has been successfully comment may not be made publicly AGENCY: Drug Enforcement submitted and there is no need to available. Comments posted to http:// Administration, Department of Justice. resubmit the same comment. Paper www.regulations.gov may include any ACTION: Notice with request for comments that duplicate electronic personal identifying information (such comments. submissions are not necessary and are as name, address, and phone number) discouraged. Should you wish to mail a included in the text of your electronic SUMMARY: The Drug Enforcement submission that is not identified as paper comment in lieu of an electronic Administration (DEA) proposes to directed above as confidential. comment, it should be sent via regular establish the 2018 aggregate production An electronic copy of this document or express mail to: Drug Enforcement quotas for controlled substances in is available at http:// Administration, Attention: DEA Federal schedules I and II of the Controlled www.regulations.gov for easy reference. Register Representative/DRW, 8701 Substances Act and assessment of Morrissette Drive, Springfield, Virginia Legal Authority annual needs for the list I chemicals 22152. ephedrine, pseudoephedrine, and Section 306 of the Controlled phenylpropanolamine. FOR FURTHER INFORMATION CONTACT: Substances Act (CSA) (21 U.S.C. 826) Michael J. Lewis, Diversion Control requires the Attorney General to DATES: Interested persons may file Division, Drug Enforcement establish aggregate production quotas written comments on this notice in Administration; Mailing Address: 8701 for each basic class of controlled accordance with 21 CFR 1303.11(c) and Morrissette Drive, Springfield, Virginia substance listed in schedules I and II 1315.11(d). Electronic comments must 22152, Telephone: (202) 598–6812. and for the list I chemicals ephedrine, be submitted, and written comments must be postmarked, on or before SUPPLEMENTARY INFORMATION: pseudoephedrine, and September 6, 2017. Commenters should phenylpropanolamine. The Attorney Posting of Public Comments be aware that the electronic Federal General has delegated this function to Please note that all comments the Administrator of the DEA pursuant Docket Management System will not received in response to this docket are accept comments after 11:59 p.m. to 28 CFR 0.100. considered part of the public record. Eastern Time on the last day of the They will, unless reasonable cause is Analysis for Proposed 2018 Aggregate comment period. given, be made available by the Drug Production Quotas and Assessment of Based on comments received in Annual Needs Enforcement Administration (DEA) for response to this notice, the The proposed year 2018 aggregate public inspection online at http:// Administrator may hold a public production quotas and assessment of www.regulations.gov. Such information hearing on one or more issues raised. In annual needs represent those quantities includes personal identifying the event the Administrator decides in of schedule I and II controlled information (such as your name, his sole discretion to hold such a substances, and the list I chemicals address, etc.) voluntarily submitted by hearing, the Administrator will publish ephedrine, pseudoephedrine, and the commenter. a notice of any such hearing in the The Freedom of Information Act phenylpropanolamine, to be Federal Register. After consideration of (FOIA) applies to all comments manufactured in the United States in any comments or objections, or after a received. If you want to submit personal 2018 to provide for the estimated hearing, if one is held, the identifying information (such as your medical, scientific, research, and Administrator will publish in the name, address, etc.) as part of your industrial needs of the United States, Federal Register a final order comment, but do not want it to be made lawful export requirements, and the establishing the 2018 aggregate publicly available, you must include the establishment and maintenance of production quotas for schedule I and II phrase ‘‘PERSONAL IDENTIFYING reserve stocks. These quotas include controlled substances, and an INFORMATION’’ in the first paragraph imports of ephedrine, pseudoephedrine, assessment of annual needs for the list of your comment. You must also place and phenylpropanolamine, but do not I chemicals ephedrine, all the personal identifying information include imports of controlled pseudoephedrine, and you do not want made publicly substances for use in industrial phenylpropanolamine. available in the first paragraph of your processes. ADDRESSES: To ensure proper handling comment and identify what information In determining the proposed 2018 of comments, please reference ‘‘Docket you want redacted. aggregate production quotas and No. DEA–471N’’ on all correspondence, If you want to submit confidential assessment of annual needs, the Acting mstockstill on DSK30JT082PROD with NOTICES including any attachments. The Drug business information as part of your Administrator has taken into account Enforcement Administration encourages comment, but do not want it to be made the criteria pursuant to 21 U.S.C. 826(a) that all comments be submitted publicly available, you must include the and in accordance with 21 CFR 1303.11 electronically through the Federal phrase ‘‘CONFIDENTIAL BUSINESS (aggregate production quotas for eRulemaking Portal which provides the INFORMATION’’ in the first paragraph controlled substances) and 21 CFR ability to type short comments directly of your comment. You must also 1315.11 (assessment of annual needs for into the comment field on the Web page prominently identify confidential ephedrine, pseudoephedrine, and VerDate Sep<11>2014 18:14 Aug 04, 2017 Jkt 241001 PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1

Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices 36831 phenylpropanolamine). The DEA 1303.12, 1315.32, and 1315.34; and (5) proposed 2018 assessment of annual proposes the aggregate production other factors affecting medical, needs, the DEA used the calculation quotas and assessment of annual needs scientific, research, and industrial needs methodology previously described in for 2018 by considering: (1) Total net of the United States and lawful export the 2010 and 2011 assessment of annual disposal of each class or chemical by all requirements, as the Acting needs (74 FR 60294, Nov. 20, 2009, and manufacturers and chemical importers Administrator finds relevant. These 75 FR 79407, Dec. 20, 2010, during the current and two preceding quotas do not include imports of respectively). years; (2) trends in the national rate of controlled substances for use in The Acting Administrator, therefore, net disposal of the class or chemical; (3) industrial processes. proposes to establish the 2018 aggregate total actual (or estimated) inventories of Other factors the Acting production quotas for certain schedule I the class or chemical and of all Administrator considered in calculating and II controlled substances and substances manufactured from the class the aggregate production quotas, but not assessment of annual needs for the list or chemical, and trends in inventory the assessment of annual needs, include I chemicals ephedrine, accumulation; (4) projected demand for product development requirements of pseudoephedrine, and each class or chemical as indicated by both bulk and finished dosage form phenylpropanolamine, expressed in procurement and import quotas manufacturers, and other pertinent grams of anhydrous acid or base, as requested in accordance with 21 CFR information. In determining the follows: Proposed 2018 Basic class quotas (g) Schedule I 1-(1-Phenylcyclohexyl)pyrrolidine ........................................................................................................................................................ 10 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201) ............................................................................................................................ 30 1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) ........................................................................................................................... 30 1-[1-(2-Thienyl)cyclohexyl]piperidine ................................................................................................................................................... 15 1-Benzylpiperazine .............................................................................................................................................................................. 25 1-Methyl-4-phenyl-4-propionoxypiperidine ........................................................................................................................................... 2 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) ........................................................................................................................... 30 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) ........................................................................................................................ 30 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) .......................................................................................................................... 30 2-(2,5-Dimethoxy-4-n-propylphenyl)ethanamine (2C-P) ...................................................................................................................... 30 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) ....................................................................................................................................... 30 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) ........................ 25 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) ........................................................................................................................ 30 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) ........................ 25 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) .............................................................................................................................. 30 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5) .................................. 30 2,5-Dimethoxy-4-ethylamphetamine (DOET) ...................................................................................................................................... 25 2,5-Dimethoxy-4-n-propylthiophenethylamine ..................................................................................................................................... 25 2,5-Dimethoxyamphetamine ................................................................................................................................................................ 25 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) ................................................................................................................ 30 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) .......................................................................................................... 30 3,4,5-Trimethoxyamphetamine ............................................................................................................................................................ 25 3,4-Methylenedioxyamphetamine (MDA) ............................................................................................................................................ 55 3,4-Methylenedioxymethamphetamine (MDMA) ................................................................................................................................. 50 3,4-Methylenedioxy-N-ethylamphetamine (MDEA) ............................................................................................................................. 40 3,4-Methylenedioxy-N-methylcathinone (methylone) .......................................................................................................................... 40 3,4-Methylenedioxypyrovalerone (MDPV) ........................................................................................................................................... 35 3-FMC; 3-Fluoro-N-methylcathinone ................................................................................................................................................... 25 3-Methylfentanyl ................................................................................................................................................................................... 30 3-Methylthiofentanyl ............................................................................................................................................................................. 30 4-Bromo-2,5-dimethoxyamphetamine (DOB) ...................................................................................................................................... 25 4-Bromo-2,5-dimethoxyphenethylamine (2-CB) .................................................................................................................................. 25 4-Fluoroisobutyryl fentanyl ................................................................................................................................................................... 30 4-FMC; Flephedrone ............................................................................................................................................................................ 25 4-MEC; 4-Methyl-N-ethylcathinone ...................................................................................................................................................... 25 4-Methoxyamphetamine ...................................................................................................................................................................... 150 4-Methyl-2,5-dimethoxyamphetamine (DOM) ...................................................................................................................................... 25 4-Methylaminorex ................................................................................................................................................................................ 25 4-Methyl-N-methylcathinone (mephedrone) ........................................................................................................................................ 45 4-Methyl-a-pyrrolidinopropiophenone (4-MePPP) ............................................................................................................................... 25 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol ......................................................................................................... 50 mstockstill on DSK30JT082PROD with NOTICES 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) ........................... 40 5F-ADB; 5F-MDMB-PINACA (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............................ 30 5F-AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ................................................................... 30 5F-APINACA; 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ........................................................ 30 5-Fluoro-PB-22; 5F-PB-22 ................................................................................................................................................................... 20 5-Fluoro-UR144, XLR11 ([1-(5-fluoro-pentyl)-1Hindol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ............................................ 25 5-Methoxy-3,4-methylenedioxyamphetamine ...................................................................................................................................... 25 5-Methoxy-N,N-diisopropyltryptamine .................................................................................................................................................. 25 VerDate Sep<11>2014 18:14 Aug 04, 2017 Jkt 241001 PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1

36832 Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices Proposed 2018 Basic class quotas (g) 5-Methoxy-N,N-dimethyltryptamine ..................................................................................................................................................... 25 AB-CHMINACA .................................................................................................................................................................................... 30 AB-FUBINACA ..................................................................................................................................................................................... 50 AB-PINACA .......................................................................................................................................................................................... 30 ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .................................. 30 Acetyl Fentanyl .................................................................................................................................................................................... 100 Acetyl-alpha-methylfentanyl ................................................................................................................................................................. 30 Acetyldihydrocodeine ........................................................................................................................................................................... 30 Acetylmethadol .................................................................................................................................................................................... 2 ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ...................................................... 50 AH-7921 ............................................................................................................................................................................................... 30 Allylprodine .......................................................................................................................................................................................... 2 Alphacetylmethadol .............................................................................................................................................................................. 2 alpha-Ethyltryptamine .......................................................................................................................................................................... 25 Alphameprodine ................................................................................................................................................................................... 2 Alphamethadol ..................................................................................................................................................................................... 2 alpha-Methylfentanyl ............................................................................................................................................................................ 30 alpha-Methylthiofentanyl ...................................................................................................................................................................... 30 alpha-Methyltryptamine (AMT) ............................................................................................................................................................ 25 alpha-Pyrrolidinobutiophenone (a-PBP) .............................................................................................................................................. 25 alpha-Pyrrolidinopentiophenone (a-PVP) ............................................................................................................................................ 25 Aminorex .............................................................................................................................................................................................. 25 APINCA, AKB48 (N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ......................................................................................... 25 Benzylmorphine ................................................................................................................................................................................... 30 Betacetylmethadol ............................................................................................................................................................................... 2 beta-Hydroxy-3-methylfentanyl ............................................................................................................................................................ 30 beta-Hydroxyfentanyl ........................................................................................................................................................................... 30 beta-Hydroxythiofentanyl ..................................................................................................................................................................... 30 Betameprodine ..................................................................................................................................................................................... 2 Betamethadol ....................................................................................................................................................................................... 4 Betaprodine .......................................................................................................................................................................................... 2 Bufotenine ............................................................................................................................................................................................ 3 Butylone ............................................................................................................................................................................................... 25 Butyryl fentanyl .................................................................................................................................................................................... 30 Cathinone ............................................................................................................................................................................................. 24 Codeine methylbromide ....................................................................................................................................................................... 30 Codeine-N-oxide .................................................................................................................................................................................. 192 Desomorphine ...................................................................................................................................................................................... 25 Diethyltryptamine ................................................................................................................................................................................. 25 Difenoxin .............................................................................................................................................................................................. 8,225 Dihydromorphine .................................................................................................................................................................................. 1,000,160 Dimethyltryptamine .............................................................................................................................................................................. 35 Dipipanone ........................................................................................................................................................................................... 5 Etorphine .............................................................................................................................................................................................. 30 Fenethylline .......................................................................................................................................................................................... 30 Furanyl fentanyl ................................................................................................................................................................................... 30 gamma-Hydroxybutyric acid ................................................................................................................................................................ 37,130,000 Heroin .................................................................................................................................................................................................. 45 Hydromorphinol .................................................................................................................................................................................... 40 Hydroxypethidine ................................................................................................................................................................................. 2 Ibogaine ............................................................................................................................................................................................... 30 JWH-018 and AM678 (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................................................................... 35 JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ........................................................................................................................................... 45 JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................................................ 45 JWH-081 (1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole) ....................................................................................................................... 30 JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) ........................................................................................................................... 30 JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ............................................................................................................... 35 JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) ............................................................................................................................ 30 JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) ........................................................................................................................ 30 JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) ............................................................................................................................ 30 Lysergic acid diethylamide (LSD) ........................................................................................................................................................ 40 MAB-CHMINACA; ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- mstockstill on DSK30JT082PROD with NOTICES carboxamide) .................................................................................................................................................................................... 30 MDMB-CHMICA; MMB-CHMINACA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ............... 30 MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ........................................... 30 Marihuana ............................................................................................................................................................................................ 443,680 Mecloqualone ....................................................................................................................................................................................... 30 Mescaline ............................................................................................................................................................................................. 25 Methaqualone ...................................................................................................................................................................................... 60 Methcathinone ..................................................................................................................................................................................... 25 VerDate Sep<11>2014 18:14 Aug 04, 2017 Jkt 241001 PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1

Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices 36833 Proposed 2018 Basic class quotas (g) Methyldesorphine ................................................................................................................................................................................. 5 Methyldihydromorphine ........................................................................................................................................................................ 2 Morphine methylbromide ..................................................................................................................................................................... 5 Morphine methylsulfonate .................................................................................................................................................................... 5 Morphine-N-oxide ................................................................................................................................................................................ 150 N,N-Dimethylamphetamine .................................................................................................................................................................. 25 Naphyrone ........................................................................................................................................................................................... 25 N-Ethyl-1-phenylcyclohexylamine ........................................................................................................................................................ 5 N-Ethylamphetamine ........................................................................................................................................................................... 24 N-Hydroxy-3,4-methylenedioxyamphetamine ...................................................................................................................................... 24 Noracymethadol ................................................................................................................................................................................... 2 Norlevorphanol ..................................................................................................................................................................................... 55 Normethadone ..................................................................................................................................................................................... 2 Normorphine ........................................................................................................................................................................................ 40 Para-fluorofentanyl ............................................................................................................................................................................... 25 Parahexyl ............................................................................................................................................................................................. 5 PB-22; QUPIC ..................................................................................................................................................................................... 20 Pentedrone .......................................................................................................................................................................................... 25 Pentylone ............................................................................................................................................................................................. 25 Phenomorphan .................................................................................................................................................................................... 2 Pholcodine ........................................................................................................................................................................................... 5 Psilocybin ............................................................................................................................................................................................. 30 Psilocyn ................................................................................................................................................................................................ 50 SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) ........................................................................................... 45 SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-benzoyl]indole) .............................................................................................................. 30 Tetrahydrocannabinols ........................................................................................................................................................................ 384,460 Thiofentanyl ......................................................................................................................................................................................... 25 THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ...................................................................................... 30 Tilidine .................................................................................................................................................................................................. 25 Trimeperidine ....................................................................................................................................................................................... 2 UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ...................................................................................... 25 U-47700 ............................................................................................................................................................................................... 30 Schedule II 1-Phenylcyclohexylamine .................................................................................................................................................................... 4 1-Piperidinocyclohexanecarbonitrile .................................................................................................................................................... 4 4-Anilino-N-phenethyl-4-piperidine (ANPP) ......................................................................................................................................... 1,342,320 Alfentanil .............................................................................................................................................................................................. 2,538 Alphaprodine ........................................................................................................................................................................................ 2 Amobarbital .......................................................................................................................................................................................... 18,894 Amphetamine (for conversion) ............................................................................................................................................................ 11,280,000 Amphetamine (for sale) ....................................................................................................................................................................... 39,856,000 Carfentanil ............................................................................................................................................................................................ 20 Cocaine ................................................................................................................................................................................................ 92,120 Codeine (for conversion) ..................................................................................................................................................................... 15,040,000 Codeine (for sale) ................................................................................................................................................................................ 40,015,800 Dextropropoxyphene ............................................................................................................................................................................ 35 Dihydrocodeine .................................................................................................................................................................................... 264,140 Dihydroetorphine .................................................................................................................................................................................. 2 Diphenoxylate (for conversion) ............................................................................................................................................................ 14,100 Diphenoxylate (for sale) ....................................................................................................................................................................... 770,800 Ecgonine .............................................................................................................................................................................................. 88,134 Ethylmorphine ...................................................................................................................................................................................... 30 Etorphine hydrochloride ....................................................................................................................................................................... 32 Fentanyl ............................................................................................................................................................................................... 1,342,320 Glutethimide ......................................................................................................................................................................................... 2 Hydrocodone (for conversion) ............................................................................................................................................................. 114,680 Hydrocodone (for sale) ........................................................................................................................................................................ 50,348,280 Hydromorphone ................................................................................................................................................................................... 4,547,720 Isomethadone ...................................................................................................................................................................................... 30 Levo-alphacetylmethadol (LAAM) ........................................................................................................................................................ 5 Levomethorphan .................................................................................................................................................................................. 30 mstockstill on DSK30JT082PROD with NOTICES Levorphanol ......................................................................................................................................................................................... 12,126 Lisdexamfetamine ................................................................................................................................................................................ 17,869,000 Meperidine ........................................................................................................................................................................................... 2,717,540 Meperidine Intermediate—A ................................................................................................................................................................ 5 Meperidine Intermediate—B ................................................................................................................................................................ 30 Meperidine Intermediate—C ................................................................................................................................................................ 5 Metazocine ........................................................................................................................................................................................... 15 Methadone (for sale) ........................................................................................................................................................................... 22,278,000 VerDate Sep<11>2014 18:14 Aug 04, 2017 Jkt 241001 PO 00000 Frm 00106 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1

36834 Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices Proposed 2018 Basic class quotas (g) Methadone Intermediate ...................................................................................................................................................................... 24,064,000 Methamphetamine ............................................................................................................................................................................... 1,446,754 [900,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 600,000 grams for methamphetamine mostly for conversion to a schedule III product; and 39,100 grams for methamphetamine (for sale)] Methylphenidate ................................................................................................................................................................................... 60,724,000 Morphine (for conversion) .................................................................................................................................................................... 4,089,000 Morphine (for sale) .............................................................................................................................................................................. 33,958,440 Nabilone ............................................................................................................................................................................................... 17,860 Noroxymorphone (for conversion) ....................................................................................................................................................... 14,044,540 Noroxymorphone (for sale) .................................................................................................................................................................. 376,000 Opium (powder) ................................................................................................................................................................................... 84,600 Opium (tincture) ................................................................................................................................................................................... 564,000 Oripavine .............................................................................................................................................................................................. 24,534,000 Oxycodone (for conversion) ................................................................................................................................................................ 2,453,400 Oxycodone (for sale) ........................................................................................................................................................................... 95,692,000 Oxymorphone (for conversion) ............................................................................................................................................................ 20,962,000 Oxymorphone (for sale) ....................................................................................................................................................................... 3,395,280 Pentobarbital ........................................................................................................................................................................................ 25,850,000 Phenazocine ........................................................................................................................................................................................ 5 Phencyclidine ....................................................................................................................................................................................... 35 Phenmetrazine ..................................................................................................................................................................................... 25 Phenylacetone ..................................................................................................................................................................................... 40 Racemethorphan ................................................................................................................................................................................. 5 Racemorphan ...................................................................................................................................................................................... 5 Remifentanil ......................................................................................................................................................................................... 2,820 Secobarbital ......................................................................................................................................................................................... 161,682 Sufentanil ............................................................................................................................................................................................. 1,880 Tapentadol ........................................................................................................................................................................................... 18,388,280 Thebaine .............................................................................................................................................................................................. 94,000,000 List I Chemicals Ephedrine (for conversion) .................................................................................................................................................................. 47,000 Ephedrine (for sale) ............................................................................................................................................................................. 4,136,000 Phenylpropanolamine (for conversion) ................................................................................................................................................ 14,100,000 Phenylpropanolamine (for sale) ........................................................................................................................................................... 7,990,000 Pseudoephedrine (for conversion) ...................................................................................................................................................... 40 Pseudoephedrine (for sale) ................................................................................................................................................................. 169,200,000 The Acting Administrator further Dated: July 27, 2017. following information collection request proposes that aggregate production Chuck Rosenberg, to the Office of Management and Budget quotas for all other schedule I and II Acting Administrator. (OMB) for review and approval in controlled substances included in 21 [FR Doc. 2017–16439 Filed 8–4–17; 8:45 am] accordance with the Paperwork CFR 1308.11 and 1308.12 remain at BILLING CODE 4410–09–P Reduction Act of 1995. zero. In accordance with 21 CFR DATES: Comments are encouraged and 1303.13 and 21 CFR 1315.13, upon will be accepted for 60 days until consideration of the relevant factors, the DEPARTMENT OF JUSTICE October 6, 2017. Acting Administrator may adjust the [OMB Number 1110–0051] FOR FURTHER INFORMATION CONTACT: If 2018 aggregate production quotas and assessment of annual needs as needed. you have additional comments Agency Information Collection especially on the estimated public Conclusion Activities; Proposed eCollection burden or associated response time, eComments Requested; Revision of a After consideration of any comments suggestions, or need a copy of the Currently Approved Collection; Final or objections, or after a hearing, if one proposed information collection Disposition Report (R–84) is held, the Acting Administrator will instrument with instructions or issue and publish in the Federal AGENCY: Criminal Justice Information additional information, please contact Register a final order establishing the Services Division, Federal Bureau of Gerry Lynn Brovey, Supervisory mstockstill on DSK30JT082PROD with NOTICES 2018 aggregate production quota for Investigation, Department of Justice. Information Liaison Specialist, FBI, controlled substances in schedules I and ACTION: 60-day notice. CJIS, Resources Management Section, II and establishing an assessment of Administrative Unit, Module C–2, 1000 annual needs for the list I chemicals SUMMARY: Department of Justice (DOJ), Custer Hollow Road, Clarksburg, West ephedrine, pseudoephedrine, and Federal Bureau of Investigation, Virginia 26306 (facsimile: 304–625– phenylpropanolamine, 21 CFR Criminal Justice Information Services 5093) or email glbrovey@ic.fbi.gov. 1303.11(c) and 1315.11(f). Division will be submitting the Written comments and/or suggestions VerDate Sep<11>2014 18:14 Aug 04, 2017 Jkt 241001 PO 00000 Frm 00107 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1


Document Created: 2017-08-05 03:00:20
Document Modified: 2017-08-05 03:00:20
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice with request for comments.
DatesInterested persons may file written comments on this notice in accordance with 21 CFR 1303.11(c) and 1315.11(d). Electronic comments must be submitted, and written comments must be postmarked, on or before September 6, 2017. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.
ContactMichael J. Lewis, Diversion Control
FR Citation82 FR 36830 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR